Multispectral optoacoustic tomography for the non-invasive identification of patients with severe anemia in vivo.

Anemia Clinical study Hemoglobin Optoacoustic imaging

Journal

Photoacoustics
ISSN: 2213-5979
Titre abrégé: Photoacoustics
Pays: Germany
ID NLM: 101622604

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 17 08 2022
revised: 29 09 2022
accepted: 10 10 2022
entrez: 24 10 2022
pubmed: 25 10 2022
medline: 25 10 2022
Statut: epublish

Résumé

The immediate diagnosis of severe anemia is crucial for patient outcome. However, reliable non-invasive point-of-care diagnostic tools for e.g., ICU monitoring are currently lacking. Using an advanced Multispectral Optoacoustic Tomography (MSOT) research device, we first substantiated a strong positive correlation of MSOT-signal and absolute hemoglobin concentration

Identifiants

pubmed: 36276233
doi: 10.1016/j.pacs.2022.100414
pii: S2213-5979(22)00079-9
pmc: PMC9583176
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100414

Informations de copyright

© 2022 The Authors.

Références

BMC Emerg Med. 2010 May 05;10:9
pubmed: 20444248
Nat Commun. 2018 Jun 15;9(1):2352
pubmed: 29907740
Opt Lett. 2010 Jul 15;35(14):2475-7
pubmed: 20634868
J Pharm Biomed Anal. 2020 Jan 30;178:112951
pubmed: 31718983
Shock. 2018 Feb;49(2):150-153
pubmed: 28727608
N Engl J Med. 2017 Mar 30;376(13):1292-1294
pubmed: 28355498
Gastroenterology. 2016 Aug;151(2):238-40
pubmed: 27269244
Clin Cancer Res. 2017 Nov 15;23(22):6912-6922
pubmed: 28899968
JCI Insight. 2020 May 21;5(10):
pubmed: 32298239
Photoacoustics. 2021 Jul 09;23:100283
pubmed: 34381689
J Biophotonics. 2018 Nov;11(11):e201800155
pubmed: 29974645
Photoacoustics. 2020 Nov 28;21:100225
pubmed: 34258221
Nat Commun. 2016 Jun 30;7:12121
pubmed: 27358000
Behav Res Methods. 2009 Nov;41(4):1149-60
pubmed: 19897823
Photoacoustics. 2021 Apr 10;22:100267
pubmed: 33948434
Photoacoustics. 2022 Mar 09;26:100345
pubmed: 35295617
Sci Transl Med. 2015 Dec 9;7(317):317ra199
pubmed: 26659573
Lasers Med Sci. 2019 Apr;34(3):487-494
pubmed: 30136213
Opt Lett. 2005 Jul 1;30(13):1677-9
pubmed: 16075535
Chem Commun (Camb). 2020 Sep 25;56(75):11102-11105
pubmed: 32812955
J Nucl Med. 2017 May;58(5):807-814
pubmed: 28126890
Biomed Opt Express. 2022 Jan 20;13(2):875-887
pubmed: 35284157
Adv Sci (Weinh). 2021 Feb 23;8(7):2003396
pubmed: 33854889
Transfus Apher Sci. 2014 Feb;50(1):95-8
pubmed: 24268769
IEEE Trans Med Imaging. 2017 Jan;36(1):322-331
pubmed: 27623576
J Nucl Med. 2019 Oct;60(10):1461-1466
pubmed: 30850507
Ann Transl Med. 2021 Jan;9(1):36
pubmed: 33553329
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
J Biomed Opt. 2020 Sep;25(9):
pubmed: 32888263
IEEE J Biomed Health Inform. 2020 Jun;24(6):1717-1726
pubmed: 31751256
Biomedicines. 2021 Apr 28;9(5):
pubmed: 33924983
Appl Opt. 2004 Jun 10;43(17):3401-7
pubmed: 15219019
Am J Surg. 2013 Dec;206(6):1041-7
pubmed: 24157223
IEEE Trans Med Imaging. 2018 Sep;37(9):2070-2079
pubmed: 29993865
Theranostics. 2017 Jul 8;7(11):2900-2913
pubmed: 28824724
Nat Med. 2019 Dec;25(12):1905-1915
pubmed: 31792454
JAMA Dermatol. 2018 Dec 1;154(12):1457-1462
pubmed: 30267083

Auteurs

Ingo Ganzleben (I)

Department of Medicine 1, University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.
Ludwig-Demling-Center for Molecular Imaging, Department of Medicine 1, University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.
Deutsches Zentrum Immuntherapie, Erlangen, Germany.

Daniel Klett (D)

Department of Medicine 1, University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.
Ludwig-Demling-Center for Molecular Imaging, Department of Medicine 1, University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.
Deutsches Zentrum Immuntherapie, Erlangen, Germany.

Wiebke Hartz (W)

Department of Medicine 1, University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.
Ludwig-Demling-Center for Molecular Imaging, Department of Medicine 1, University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.
Deutsches Zentrum Immuntherapie, Erlangen, Germany.

Lisa Götzfried (L)

Department of Medicine 1, University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.
Ludwig-Demling-Center for Molecular Imaging, Department of Medicine 1, University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.
Deutsches Zentrum Immuntherapie, Erlangen, Germany.

Francesco Vitali (F)

Department of Medicine 1, University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.
Ludwig-Demling-Center for Molecular Imaging, Department of Medicine 1, University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.
Deutsches Zentrum Immuntherapie, Erlangen, Germany.

Markus F Neurath (MF)

Department of Medicine 1, University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.
Ludwig-Demling-Center for Molecular Imaging, Department of Medicine 1, University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.
Deutsches Zentrum Immuntherapie, Erlangen, Germany.
Erlangen Graduate School in Advanced Optical Technologies (SAOT), Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.

Maximilian J Waldner (MJ)

Department of Medicine 1, University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.
Ludwig-Demling-Center for Molecular Imaging, Department of Medicine 1, University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.
Deutsches Zentrum Immuntherapie, Erlangen, Germany.
Erlangen Graduate School in Advanced Optical Technologies (SAOT), Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.

Classifications MeSH